Guidelines for the management of hyperlipidemia: How can clinicians effectively implement them?

Area of Science:

• Cardiology
• Public Health
• Pharmacotherapy

Background:

• Current guidelines recommend cholesterol lowering for atherosclerotic cardiovascular disease (ASCVD) risk management.
• Statin therapy is a cornerstone for high-risk individuals, with modest improvements in its use over time.
• A persistent treatment gap remains, indicating suboptimal guideline implementation.

Purpose of the Study:

• To highlight the ongoing challenges in implementing cholesterol-lowering guidelines for ASCVD risk reduction.
• To emphasize the need for addressing barriers within the healthcare system to improve guideline adherence.
• To advocate for further research into sustainable interventions for better guideline implementation.

Main Methods:

• Review of existing literature and studies on statin therapy initiation, use, and adherence in ASCVD patients.
• Analysis of documented treatment gaps in guideline implementation.
• Identification of healthcare delivery system barriers impacting guideline success.

Main Results:

• While some progress has been made, statin therapy implementation for ASCVD risk remains suboptimal.
• A substantial and persistent treatment gap exists, underscoring challenges in guideline adherence.
• Various barriers within the healthcare system impede the effective translation of guidelines into practice.

Conclusions:

• Effective implementation of cholesterol-lowering guidelines requires addressing systemic barriers.
• Further comprehensive research is essential to develop targeted and sustainable interventions.
• Improving guideline adherence is critical for reducing ASCVD risk across patient populations.